69 related articles for article (PubMed ID: 34645168)
21. Camrelizumab and apatinib combined with chemotherapy in perioperative effective therapy for advanced gastric carcinoma with peritoneal metastasis: a case report.
Liang S; Fang X; Jiang P; Yang L; Li X; Xu X; Liang Y; Li C; Zheng Y
J Gastrointest Oncol; 2023 Dec; 14(6):2658-2667. PubMed ID: 38196525
[TBL] [Abstract][Full Text] [Related]
22. Segmentation of Gastric Computerized Tomography Images under Intelligent Algorithms in Evaluation of Efficacy of Decitabine Combined with Paclitaxel in Treatment of Gastric Cancer.
Ge Z; Wang M; Liu Q
J Healthc Eng; 2021; 2021():8023490. PubMed ID: 34745511
[TBL] [Abstract][Full Text] [Related]
23. Safety of apatinib plus S-1 for advanced solid tumor as palliative treatment.
Chen S; Sun J; Zhao L; Sun Y; Jia D; Song Y; Luo J; Lei H; Liu N
Exp Ther Med; 2021 Jan; 21(1):62. PubMed ID: 33365062
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of Apatinib plus S-1 Therapy in the Treatment of Advanced Gastric Cancer Patients and the Effect on the Levels of Tumor Markers and Th1 and Th2-Like Cytokines.
Gu J; Ni X; Ji J; Wei G; Shi L; Xu C
Evid Based Complement Alternat Med; 2022; 2022():8060026. PubMed ID: 35529932
[TBL] [Abstract][Full Text] [Related]
25. Clinical efficacy of apatinib in treating metastatic gastric cancer and its effect on IL-17.
Chen R; Chen QT; Dong YH
Oncol Lett; 2019 Jun; 17(6):5447-5452. PubMed ID: 31186764
[TBL] [Abstract][Full Text] [Related]
26. A gastric neuroendocrine carcinoma with good prognosis after chemotherapy combined with immunotherapy: A case report (CARE-compliant).
Zhao Y; Yang R; Lu H
Medicine (Baltimore); 2023 Dec; 102(50):e36568. PubMed ID: 38115336
[TBL] [Abstract][Full Text] [Related]
27. Remarkable Response of Metastatic Gallbladder Carcinoma to Apatinib After Failed Multiline Chemotherapies: A Case Report and Literature Review.
Zhang M; Zhang P; Zhou K; Li Q
Front Oncol; 2019; 9():1180. PubMed ID: 31788447
[TBL] [Abstract][Full Text] [Related]
28. Clinical significance of intraperitoneal paclitaxel combined with systemic chemotherapy for gastric cancer with peritoneal metastasis.
Nakashima T; Arigami T; Uenosono Y; Matsushita D; Shimonosono M; Tsuruda Y; Sasaki K; Baba K; Kurahara H; Ohtsuka T
Int J Clin Oncol; 2023 Oct; 28(10):1371-1377. PubMed ID: 37432613
[TBL] [Abstract][Full Text] [Related]
29. Meta-analysis of the Efficacy and Safety of Trastuzumab Combined with Apatinib in the Treatment of Advanced Gastric Cancer.
Yue J; Long Z
Altern Ther Health Med; 2023 Dec; ():. PubMed ID: 38064625
[TBL] [Abstract][Full Text] [Related]
30. Apatinib plus chemotherapy for non-metastatic osteosarcoma: a retrospective cohort study.
Wang J; Zhang F; Dong S; Yang Y; Gao F; Liu G; Zhang P; Wang X; Du X; Tian Z
Front Oncol; 2023; 13():1227461. PubMed ID: 38023239
[TBL] [Abstract][Full Text] [Related]
31. Study protocol of a phase II clinical trial evaluating the efficacy of neoadjuvant intraperitoneal and systemic albumin-bound paclitaxel combined with camrelizumab and S-1 in the treatment of patients with exfoliative cell-positive gastric cancer.
Lv J; Wu J; Wu H; Ding P; Guo H; Yang P; Tian Y; Liu Y; Zhao Q
Front Oncol; 2023; 13():1201928. PubMed ID: 37841441
[TBL] [Abstract][Full Text] [Related]
32. Effects of Apatinib Mesylate Monotherapy on the Incidence of Adverse Reactions and Immune Function in Patients with Breast Cancer after Radical Mastectomy.
Lin S; Zang M
Evid Based Complement Alternat Med; 2022; 2022():4022282. PubMed ID: 35990841
[TBL] [Abstract][Full Text] [Related]
33. The Clinical Implication of Conversion Surgery in Patients with Stage IV Gastric Cancer Who Received Systemic Chemotherapy.
Shin MK; Choi MG; Kim ST; Kang WK; Sohn TS; An JY; Lee JH; Lee JY
Biomedicines; 2023 Nov; 11(11):. PubMed ID: 38002099
[TBL] [Abstract][Full Text] [Related]
34. Low Expectancy of Conversion Surgery with R0 Resection in Patients with CEA > 5.0 ng/mL at the Initial RECIST Evaluation for Metastatic Gastric Cancer.
Nakanishi K; Tanaka C; Kanda M; Miyata K; Furukawa K; Maeda O; Shimizu D; Sugita S; Kakushima N; Furune S; Kawashima H; Ando Y; Ebata T; Kodera Y
Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958371
[TBL] [Abstract][Full Text] [Related]
35. S-1 maintenance therapy in advanced gastric cancer without disease progression after first-line chemotherapy: A retrospective analysis.
Li L; Wang T; Wu Z; Li Y; Ma H; Wang L; Lei S
Sci Prog; 2023; 106(4):368504231212792. PubMed ID: 38130176
[TBL] [Abstract][Full Text] [Related]
36. A case report of low-dose apatinib in the treatment of advanced triple-negative breast cancer.
Lv Y; Zhang H; Zhao Y; Zhang H; Wang T
Transl Breast Cancer Res; 2024; 5():8. PubMed ID: 38751676
[TBL] [Abstract][Full Text] [Related]
37. [Early Efficacy Observation of Pomalidomide-based Regimen in the Treatment of High-risk Multiple Myeloma].
Li CC; Zhang WY; Zhang RJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Auguest; 31(5):1432-1436. PubMed ID: 37846696
[TBL] [Abstract][Full Text] [Related]
38. Genomic and immune microenvironment features influencing chemoimmunotherapy response in gastric cancer with peritoneal metastasis: a retrospective cohort study.
Yu P; Ding G; Huang X; Wang C; Fang J; Huang L; Ye Z; Xu Q; Wu X; Yan J; Ou Q; Du Y; Cheng X
Int J Surg; 2024 Mar; ():. PubMed ID: 38502852
[TBL] [Abstract][Full Text] [Related]
39. Two autopsied gastric cancer cases of rare drug-induced pneumonia associated with nivolumab plus S-1 and oxaliplatin: a case report.
Noumi T; Kimura S; Fushimi T; Sakamoto S; Nakamura K; Fushimi S; Ohara T; Mashimo S; Tao H; Watanabe T; Kishino D
J Gastrointest Oncol; 2024 Feb; 15(1):491-499. PubMed ID: 38482223
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of nature killer cell combination chemotherapy for post-radical gastric cancer metastases: Case report.
Yue Y; Zi M; Feng J; Wang W; Ren Z; Wu C; Yang Z
SAGE Open Med Case Rep; 2024; 12():2050313X241254743. PubMed ID: 38803362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
